Invention Grant
- Patent Title: CRISPR nuclease
-
Application No.: US17594761Application Date: 2020-04-30
-
Publication No.: US11666641B2Publication Date: 2023-06-06
- Inventor: David Baram , Lior Izhar , Asael Herman , Liat Rockah , Nadav Marbach-Bar , Nurit Meron , Joseph Georgeson
- Applicant: EmendoBio Inc.
- Applicant Address: US DE Wilmington
- Assignee: EMENDOBIO INC.
- Current Assignee: EMENDOBIO INC.
- Current Assignee Address: US DE Wilmington
- Agent Gary J. Gershik
- International Application: PCT/US2020/030782 2020.04.30
- International Announcement: WO2020/223514A 2020.11.05
- Date entered country: 2021-10-28
- Main IPC: C12N9/22
- IPC: C12N9/22 ; A61K38/46 ; A61K31/7105 ; C12N15/11 ; C12N15/90
Abstract:
The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 3 or a nucleic acid molecule comprising a sequence encoding the CRISPR nuclease.
Public/Granted literature
- US20220202913A1 NOVEL OMNI-50 CRISPR NUCLEASE Public/Granted day:2022-06-30
Information query
